Position in ONC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,260,730
-$4,208,135 QoQ
Shares Held
10,980
-55.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in ONC
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,260,730 | 10,980 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,468,865 | 24,584 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,384,173 | 9,933 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,608,295 | 14,906 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $3,053,336 | 13,600 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,032,684 | 35,275 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,841,762 | 18,171 | Shares | Sole | 2024-05-14 | |
| 2021-06-30 | $6,672,299 | 19,442 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $1,178,127 | 4,113 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,328,973 | 7,054 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||